BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9130986)

  • 1. Endometrioid endometrial adenocarcinoma with psammoma bodies.
    Parkash V; Carcangiu ML
    Am J Surg Pathol; 1997 Apr; 21(4):399-406. PubMed ID: 9130986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological findings in early-stage endometrial cancer.
    Zehavi S; Schneider D; Bukovsky I; Halperin R
    Eur J Gynaecol Oncol; 2003; 24(1):18-20. PubMed ID: 12691310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should omentectomy be a part of surgical staging in patients with endometrioid adenocarcinoma of the uterine corpus?
    Ulker V; Tunca A; Numanoglu C; Akbayir O; Akyol A; Erim A; Ongut C
    Gynecol Obstet Invest; 2014; 77(1):58-63. PubMed ID: 24356379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathologic diagnosis of endometrial carcinoma in curettage specimens in women under forty years of age].
    Wang MQ; Zhang QH; Guo LL; Cai YR; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):262-5. PubMed ID: 16181545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well differentiated endometrioid adenocarcinoma of the uterus: a cancer unit or centre case?
    Montalto SA; Hakmi A; Moth P; Raju KS; Coutts M; Papadopoulos AJ; Devaja O
    Eur J Gynaecol Oncol; 2009; 30(1):35-9. PubMed ID: 19317254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
    Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
    Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian preservation in young women with endometrial cancer of endometrioid histology.
    Kinjyo Y; Kudaka W; Ooyama T; Inamine M; Nagai Y; Aoki Y
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):430-4. PubMed ID: 25603833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53, estrogen and progesterone receptors in diagnostic curettage for endometrial adenocarcinoma and their correlation with morphological data and disease stage at hysterectomy.
    Bonfitto VL; de Angelo Andrade LA
    Sao Paulo Med J; 2003 Jul; 121(4):163-6. PubMed ID: 14595509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis.
    Hertel JD; Huettner PC; Pfeifer JD
    Int J Gynecol Pathol; 2014 Mar; 33(2):127-34. PubMed ID: 24487466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical mucinous glandular proliferations in endometrial samplings: follow-up and other clinicopathological findings in 41 cases.
    Rawish KR; Desouki MM; Fadare O
    Hum Pathol; 2017 May; 63():53-62. PubMed ID: 28232161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
    Fadare O; Parkash V
    Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
    Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
    Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer.
    Tanaka T; Terai Y; Ono YJ; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Kanemura M; Yamamoto K; Yamada T; Ohmichi M
    Int J Gynecol Cancer; 2015 Jun; 25(5):879-83. PubMed ID: 25950131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
    Tambouret R; Clement PB; Young RH
    Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Histologic Regression of Endometrioid Adenocarcinoma on Endometrial Biopsy After Progestin Treatment Does Not Guarantee the Regression of an Invasive Carcinoma Within the Myometrium.
    Park JY; Park JY; Nam JH; Kim KR
    Int J Gynecol Pathol; 2019 Jan; 38(1):66-70. PubMed ID: 29257040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.